Advertisement
Canada markets closed

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7255
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    84.69
    +1.96 (+2.37%)
     

  • Bitcoin CAD

    85,445.74
    +733.42 (+0.87%)
     

  • CMC Crypto 200

    1,286.62
    +401.08 (+44.06%)
     

  • GOLD FUTURES

    2,407.30
    +9.30 (+0.39%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • NASDAQ futures

    17,368.50
    -178.75 (-1.02%)
     

  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    37,053.95
    -1,025.75 (-2.69%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc

ACCESSWIRE

New York, December 11, 2013 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for CytRx Corporation(NASDAQ:CYTR - News), Echo Therapeutics Inc(NASDAQ:ECTE - News), Advanced Micro Devices, Inc.(NYSE:AMD - News), Baidu Inc (ADR)(NASDAQ:BIDU - News).

CytRx Corporation(NASDAQ:CYTR - News) is out with top-line results from a Phase 2b study of aldoxorubicin in first-line metastatic, locally advanced or unresectable STSs.Summary (intent-to-treat analysis): Median PFS for aldoxorubicin, 8.4 months; median PFS for doxorubicin, 4.7 months.Summary (blinded central lab review): Median PFS for aldoxorubicin, 5.7 months; median PFS for doxorubicin, 2.8 months.OR rate: 25.4% for aldoxorubicin, 5.4% for doxorubicin."These results are extraordinary for a single agent treating these chemotherapy-resistant tumors," the study's principal investigator says.

Free Urgent Insider Catalyst Report For CYTR Available Here: http://marketbuzzreport.com/index.php?code=CYTR (Or Copy and paste the URL into your browser)

After rallying 8% Tuesday, shares of Echo Therapeutics Inc(NASDAQ:ECTE - News) are up some 26% in premarket action.The company has inked a licensing, development, and commercialization agreement with Medical Technologies Innovation Asia for the manufacture and distribution of the Symphony CGM System in China, Hong Kong, Macau, and Taiwan.Medical Technologies Innovation will take on the development, marketing, and manufacturing costs for the Chinese market, and will also be responsible for "obtaining regulatory approval for the product in the licensed territories."Medical Technologies Innovation is also entitled to $1.5M in development cost reimbursement, payable in ECTE stock.The companies will share any net sales of the system in the region.

ADVERTISEMENT

Free Urgent Insider Catalyst Report For ECTE Available Here: http://marketbuzzreport.com/index.php?code=ECTE (Or Copy and paste the URL into your browser)

Interest in using high-end Advanced Micro Devices, Inc.(NYSE:AMD - News) GPUs to mine Litecoins (a rival cryptocurrency to Bitcoins) has triggered shortages for graphics cards running R9 280X and R9 290/290X GPUs.15 of the 17 R9 280X graphics cards offered by Newegg are out of stock, as are 14 out of 16 R9 290/290X GPUs.With Litecoin trading at a fraction of Bitcoin's price, the former is much easier to mine than the latter. However, Litecoin mining does require considerable amounts of memory and GPU horsepower.AMD GPUs are viewed as far more efficient at mining Litecoins than Nvidia (NVDA +1.9%) GPUs, but both can be applied to the task.AMD launched its R9 and R7 GPUs earlier this fall, and priced them aggressively relative to Nvidia's high-end GTX 780/770 and Titan GPUs; Nvidia announced price cuts in response.Notable Calls reports hearing from IT hardware contacts the R9/R7 launches have led AMD to take GPU share from Nvidia.

Free Urgent Insider Catalyst Report For AMD Available Here: http://marketbuzzreport.com/index.php?code=AMD (Or Copy and paste the URL into your browser)

Pac Crest (Outperform) says its Chinese checks indicate Baidu Inc (ADR)(NASDAQ:BIDU - News) Q4 trends are stable, at the company's growth rate can match that of the Chinese search market going forward.Though shares have risen sharply this year thanks to improved ad monetization (particularly on mobile) and a general rally in Chinese Internet stocks, concerns about search share losses to Qihoo (QIHU +1.4%) and (to a lesser extent) Sohu's (SOHU +2%) Sogou unit have persisted.Research firm CNZZ estimates Baidu had a 61.7% Chinese search share in October, down from 73.5% a year earlier. Over the same time, Qihoo's share surged to 21.4% from 9.8%, and Sogou's rose to 10.5% from 7.5%.

Free Urgent Insider Catalyst Report For BIDU Available Here: http://marketbuzzreport.com/index.php?code=BIDU (Or Copy and paste the URL into your browser)

USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)